G2GBIO Joins CPHI China 2026 to Accelerate Global Dealmaking
G2GBIO has announced its participation in the upcoming CPHI China 2026 event. The company aims to use this platform to accelerate its global dealmaking activities. 더바이오 reports that this move is
G2GBIO has announced its participation in the upcoming CPHI China 2026 event. The company aims to
use this platform to accelerate its global dealmaking activities. 더바이오 reports that this move is
part of a broader strategy to expand international partnerships. CPHI China serves as a major hub
for pharmaceutical and biotechnology industry networking. By joining the event, G2GBIO seeks to
connect with key players and potential business partners. The focus on dealmaking highlights the
company's aggressive growth targets in the biotech sector. This participation will provide G2GBIO
with increased visibility among a global audience of industry leaders. The company expects to secure
significant strategic alliances during the course of the event.